Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Net Income: 2020-2025

Historic Net Income for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$6.6 million.

  • Biofrontera's Net Income fell 17.29% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 36.89%. This contributed to the annual value of -$17.8 million for FY2024, which is 11.78% up from last year.
  • Biofrontera's Net Income amounted to -$6.6 million in Q3 2025, which was down 24.89% from -$5.3 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Net Income registered a high of $5.6 million during Q1 2022, and its lowest value of -$16.0 million during Q3 2021.
  • For the 3-year period, Biofrontera's Net Income averaged around -$4.9 million, with its median value being -$5.7 million (2024).
  • Per our database at Business Quant, Biofrontera's Net Income skyrocketed by 257.36% in 2022 and then crashed by 1,971.60% in 2025.
  • Over the past 5 years, Biofrontera's Net Income (Quarterly) stood at -$14.5 million in 2021, then spiked by 80.80% to -$2.8 million in 2022, then surged by 226.61% to $3.5 million in 2023, then crashed by 139.59% to -$1.4 million in 2024, then declined by 17.29% to -$6.6 million in 2025.
  • Its Net Income stands at -$6.6 million for Q3 2025, versus -$5.3 million for Q2 2025 and -$4.2 million for Q1 2025.